Nov. 8, 2018 Price forecast | 2 weeks: 0.39% | 1 month: 1.11% | 3 months: 1.66%

HOLX stock forecast

Our latest prediction for Hologic, Inc.'s stock price was made on the Nov. 8, 2018 when the stock price was at 42.46$.

In the short term (2weeks), HOLX's stock price should outperform the market by 0.39%. During that period the price should oscillate between -3.71% and +3.89%.

In the medium term (3months), HOLX's stock price should outperform the market by 1.66%. During that period the price should oscillate between -7.94% and +10.84%.

About Hologic, Inc.

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following business segments: Breast Health, Diagnostics, Medical Aesthetics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a broad portfolio of breast imaging and related products and accessories, including digital mammography systems, computer-aided detection, for mammography and minimally invasive breast biopsy devices, breast biopsy site markers, and breast biopsy guidance systems. The Diagnostics segment comprises Aptima family of Assays, target capture/nucleic acid extraction techonolgy, transcription-mediated amplification technology, hybridization protection assay and dual kinetic assat technologies, instrumentation, and Invader Chemistry Platform. The Medical Aesthetics segment offers SculpSure; PicoSure, MedLite, and RevLite; and MonaLisa Touch. The GYN Surgical segment encompasses the NovaSure Endometrial Ablation System and the MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment covers the discovery and horizon X-ray bone densitometry system, an ultrasound-based osteoporosis assessment product, and Fluoroscan mini C-arm imaging products. The company was founded by S. David Ellenbogen and Jay A. Stein in 1986 and is headquartered in Marlborough, MA.

At the moment the company generates 3286M USD in revenues.

On its last earning announcement, the company reported a loss of -0.05$ per share.

The book value per share is 9.00$

Hologic, Inc. website

Three months stock forecastNov. 8, 2018


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
3286M 40.60% 130M 4.00% -10M -0.05 - - 272M 9.00 705M -109M 595M